BostonGene Corporation
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- $150M
Investors
- 3
About BostonGene Corporation
Founded in 2015 in Waltham, US, BostonGene Corporation operates in the field of precision medicine, specializing in oncology.BostonGene Corporation specializes in delivering advanced precision medicine solutions through its proprietary Multiomic AI Platform. This platform integrates various data types, including genomic, transcriptomic, and proteomic information, to facilitate the identification of biomarkers, enhance clinical trial designs, and support drug development processes. Core offerings encompass the Tumor Portrait™ test, Liquid Biopsy test, and Immune System Profiling, all aimed at addressing unmet medical needs in oncology and improving patient outcomes.BostonGene generates revenue through partnerships and collaborations with leading biopharmaceutical companies, as well as direct service offerings to healthcare institutions. Transactions typically occur via contractual agreements for the provision of its suite of diagnostic and profiling services, including its flagship Tumor Portrait™ test. The company engages primarily in B2B interactions, delivering its services to clinical partners who utilize the data for enhancing patient treatment strategies. Revenue streams may also include subscriptions for ongoing access to its Multiomic AI Platform, allowing clients to integrate advanced analytics into their research and clinical workflows. The company is focused on launching new products and enhancing its offerings to meet the increasing demand in the oncology space.
Who invested in BostonGene Corporation
3 investors across 1 round
See all investors in BostonGene Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 6, 2022
Amount
$150M
Investors
Questions about BostonGene Corporation
Who invested in BostonGene Corporation?
BostonGene Corporation has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BostonGene Corporation raised?
BostonGene Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BostonGene Corporation last raise money?
BostonGene Corporation's most recent round on record is a Series B, in Apr 2022.
What does BostonGene Corporation do?
Founded in 2015 in Waltham, US, BostonGene Corporation operates in the field of precision medicine, specializing in oncology.
Where is BostonGene Corporation headquartered?
BostonGene Corporation is headquartered in Waltham, US.
Which VCs invest in companies like BostonGene Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at BostonGene Corporation's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like BostonGene Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.